Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Cookson

Showing results (51-60 of 320) with videos related to

Pageof 32
Sort By:
The Biochemical Journal|August 28, 2010
14-3-3 proteins are promising LRRK2 interactorsIakov N Rudenko, Mark R Cookson
Journal of Parkinson'S Disease|June 21, 2024
How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell TypesHannah M Bailey, Mark R Cookson
Molecular Neurodegeneration|December 9, 2016
LRRK2 at the interface of autophagosomes, endosomes and lysosomesDorien A Roosen, Mark R Cookson
Antioxidants & Redox Signaling|May 17, 2011
Mitochondrial quality control and dynamics in Parkinson's diseaseMelissa K McCoy, Mark R Cookson
Progress in Brain Research|April 6, 2020
Pathways of protein synthesis and degradation in PD pathogenesisRebekah G Langston, Mark R Cookson
Molecular Biology of the Cell|August 31, 2022
The endoplasmic reticulum contributes to lysosomal tubulation/sorting driven by LRRK2Luis Bonet-Ponce, Mark R Cookson
Current Opinion in Cell Biology|May 5, 2019
The role of Rab GTPases in the pathobiology of Parkinson' diseaseLuis Bonet-Ponce, Mark R Cookson
Stem Cell Research|May 25, 2023
Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantNikita Kozhushko, Aleksandra Beilina, Mark R Cookson
Experimental Neurology|July 3, 2007
Cell systems and the toxic mechanism(s) of alpha-synucleinMark R Cookson, Marcel van der Brug
Current Opinion in Neurology|November 11, 2005
How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the diseaseMark R Cookson, Georgia Xiromerisiou, Andrew Singleton
Pageof 32

Showing results (51-60 of 320) with videos related to

Sort By:
Pageof 32
The Biochemical Journal|August 28, 2010
14-3-3 proteins are promising LRRK2 interactorsIakov N Rudenko, Mark R Cookson
Journal of Parkinson'S Disease|June 21, 2024
How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell TypesHannah M Bailey, Mark R Cookson
Molecular Neurodegeneration|December 9, 2016
LRRK2 at the interface of autophagosomes, endosomes and lysosomesDorien A Roosen, Mark R Cookson
Antioxidants & Redox Signaling|May 17, 2011
Mitochondrial quality control and dynamics in Parkinson's diseaseMelissa K McCoy, Mark R Cookson
Progress in Brain Research|April 6, 2020
Pathways of protein synthesis and degradation in PD pathogenesisRebekah G Langston, Mark R Cookson
Molecular Biology of the Cell|August 31, 2022
The endoplasmic reticulum contributes to lysosomal tubulation/sorting driven by LRRK2Luis Bonet-Ponce, Mark R Cookson
Current Opinion in Cell Biology|May 5, 2019
The role of Rab GTPases in the pathobiology of Parkinson' diseaseLuis Bonet-Ponce, Mark R Cookson
Stem Cell Research|May 25, 2023
Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantNikita Kozhushko, Aleksandra Beilina, Mark R Cookson
Experimental Neurology|July 3, 2007
Cell systems and the toxic mechanism(s) of alpha-synucleinMark R Cookson, Marcel van der Brug
Current Opinion in Neurology|November 11, 2005
How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the diseaseMark R Cookson, Georgia Xiromerisiou, Andrew Singleton
Pageof 32